Switch to: References

Add citations

You must login to add citations.
  1. The Social Value Misconception in Clinical Research.Jake Earl, Liza Dawson & Annette Rid - forthcoming - American Journal of Bioethics.
    Clinical researchers should help respect the autonomy and promote the well-being of prospective study participants by helping them make voluntary, informed decisions about enrollment. However, participants often exhibit poor understanding of important information about clinical research. Bioethicists have given special attention to “misconceptions” about clinical research that can compromise participants’ decision-making, most notably the “therapeutic misconception.” These misconceptions typically involve false beliefs about a study’s purpose, or risks or potential benefits for participants. In this article, we describe a misconception involving (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Enhancing social value considerations in prioritising publicly funded biomedical research: the vital role of peer review.Katherine W. Saylor & Steven Joffe - 2024 - Journal of Medical Ethics 50 (4):253-257.
    The main goal of publicly funded biomedical research is to generate social value through the creation and application of knowledge that can improve the well-being of current and future people. Prioritising research with the greatest potential social value is crucial for good stewardship of limited public resources and ensuring ethical involvement of research participants. At the National Institutes of Health (NIH), peer reviewers hold the expertise and responsibility for social value assessment and resulting prioritisation at the project level. However, previous (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Risk, benefit, and social value in Covid-19 human challenge studies: pandemic decision making in historical context.Mabel Rosenheck - 2022 - Monash Bioethics Review 40 (2):188-213.
    AbstractDuring the Covid-19 pandemic, ethicists and researchers proposed human challenge studies as a way to speed development of a vaccine that could prevent disease and end the global public health crisis. The risks to healthy volunteers of being deliberately infected with a deadly and novel pathogen were not low, but the benefits could have been immense. This essay is a history of the three major efforts to set up a challenge model and run challenge studies in 2020 and 2021. The (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • (1 other version)Exploring the ethics of tuberculosis human challenge models.Abie Rohrig, Josh Morrison, Gavriel Kleinwaks, Jonathan Pugh, Helen McShane & Julian Savulescu - forthcoming - Journal of Medical Ethics.
    We extend recent conversation about the ethics of human challenge trials to tuberculosis (TB). TB challenge studies could accelerate vaccine development, but ethical concerns regarding risks to trial participants and third parties have been a limiting factor. We analyse the expected social value and risks of different challenge models, concluding that if a TB challenge trial has between a 10% and a 50% chance of leading to the authorisation and near-universal delivery of a more effective vaccine 3–5 years earlier, then (...)
    Download  
     
    Export citation  
     
    Bookmark